Bioavailability Study of MGL-3196 Tablets Compared to Capsules
Clinical trial NCT03413124 · COMPLETED
Trial details
- NCT number
- NCT03413124
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2018-02-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.